Skip to Content

Lazard International Small Cap Eq Instl LZISX

Medalist Rating as of | See Lazard Investment Hub
  • NAV / 1-Day Return 8.61  /  +1.53 %
  • Total Assets 10.6 Mil
  • Adj. Expense Ratio
    1.030%
  • Expense Ratio 1.030%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Foreign Small/Mid Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 10,000
  • Status Open
  • TTM Yield 2.14%
  • Turnover 45%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis LZISX

Will LZISX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Lazard International Small Cap Eq Instl's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LZISX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 17.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Zealand Pharma A/S

2.07 216,779
Healthcare

JTC PLC Ordinary Shares

1.88 196,870
Financial Services

Britvic PLC

1.87 196,400
Consumer Defensive

SBI Sumishin Net Bank Ltd

1.82 190,244
Financial Services

Arca Continental SAB de CV

1.79 187,304
Consumer Defensive

Jumbo SA

1.74 182,342
Consumer Cyclical

USS Co Ltd

1.66 174,213
Consumer Cyclical

AUB Group Ltd

1.63 170,503
Financial Services

CTP NV Ordinary Shares

1.51 157,770
Real Estate

Kemira Oyj

1.51 157,710
Basic Materials